Vanda Pharmaceuticals Inc.

DC · United States · Reporting entity ID 100000071361

Total reported 2019–2025

$101.7M

#94 of 2,960 reporting companies — 0.1% of all reported industry payments

$16.5M in general payments across 231,873 records, plus $85.2M in research funding across 6,456 records.

How it breaks down

General payments $16,518,399

Research funding $85,161,868

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.